Epigenetic Therapies and Technologies: WTF???

Well, I do not know how to present the information regarding epigenetic therapies and technologies that I have obtained as an advertisement in my e-mail address... But several quotes to start:

Research and development - see trends and possibilities

What's happening in epigenetic R&D? You see trends and outlooks there:
• HDAC inhibitors
• DNMT inhibitors
• Treatments targeting other enzymes
• MiRNA therapy
• Diagnostics pipeline.

Our study also discusses these technologies, among others:
• New drug targets
• Biomarkers
• Bioinformatics
• Next generation sequencing.

Discover progress. You assess innovations affecting the industry's future - hear about developments and find their significance. Our work explains, exploring many issues.

What affects the application of epigenetics?

Our report discusses issues and events affecting that science, industry and market from 2013 onwards:
• Cancer research and treatment
• DNA hypomethylation in autoimmune diseases
• Neurodegenerative diseases
• Neurological disorders
• Understanding of epigenetic markers and mechanisms.

Also, you find coverage of these aspects of the field:
• Genomics, proteomics and metabolomics
• Translational research
• Licensing, outsourcing and academic collaborations
• Developments with stem cells
• Orphan indications and patient subpopulations
• Companion diagnostics and stratified medicine.

See what the future holds. You investigate technological, commercial, economic and political matters, with emphasis on companies, competition and business outlooks.

Leading companies and market value

Overall world revenue for epigenetic applications will reach $2,518m in 2013, our report forecasts. The R&D pipeline is diverse and promising. That industry holds great potential for further investment, development and growth.

I need to check the definition: what does "epigenetic therapies" mean...  And the revenue of $2.5m looks not very serious, as well as the term "epigenetic therapies"!